Huge revenue increase Merck KGaA expected

Huge increase Merck KGaA KGaA expected

Over the past book year the analyst estimate the revenue to be around 12,85 billion euros. This is way more than the 2014's revenue of 11,5 billion euros. The consensus of the analysts for 2015 is a net profit of 2,12 billion euros.

For 2015 the consensus of the earnings per share of Merck KGaA is at profit of 4,88 euros. Based on this the price/earnings-ratio equals 16,32.

The consensus of the dividends per share is at 1,08 euros.Consequently the dividend return is around 1,36 percent. On average the stocks in this sector yield a dividend return of around 0,52 percent.

The stock Merck KGaA is covered by 21 analysts. The average target price for Merck KGaA is at 97,20 euros. This is 220400 percent more than the current stock price of 79,64 euros.

The stocks Mithra, Kiadis and Roche in the sector pharmaceutical sector have the most buy recommendations. The 3 most recent recommendations for the pharmaceutical sector were provided by Equinet-ag (hold, 96,00 euros), Deutsche Bank (buy, 88,00 euros) and Commerzbank (buy, 95,00 euros).

Merck KGaA's book value/price equals 0,23. The pharmaceutical company now trades at a Shiller PE of 23.58. The stock now trades at 79,64 euros. This equals 60 times the 2014's earnings per share.